Susanne Muehlschlegel MD, MPH
Title | Associate Professor |
---|
Institution | University of Massachusetts Medical School |
---|
Department | Neurology |
---|
Phone | 508-856-2527 |
---|
vCard | Download vCard |
---|
|
|
|
|
Institution | UMMS - School of Medicine |
---|
Department | Anesthesiology and Perioperative Medicine |
---|
|
|
---|
|
Institution | UMMS - School of Medicine |
---|
Department | Neurology |
---|
|
|
---|
|
Institution | UMMS - School of Medicine |
---|
Department | Surgery |
---|
|
|
---|
|
ORNG Applications Biography Hohe Landesschule Hanau, Hanau, , Germany | BA | | Chemistry/ English | Harvard University School of Public Health, Boston, MA, United States | MPH | | Public Health/ Clinical Effect | Phillipps University of Marburg, Marburg, Germany | Dr. med. | 11/2002 | Molecular Oncology | Philipp University of Marburg, Marburg, , Germany | MD | | Medicine | University of Florida, Gainesville, FL | Residency | 06/2006 | Neurology | MassGeneral Hospital/Brigham Women's Hospital, Harvard Medical School, Boston, MA | | 06/2008 | Neurocritical Care and Vascular Neurology |
1995 - 2002 | Studienstiftung des Deutschen Volkes (German National Merit) Scholarship , Studienstiftung des Deutschen Volkes | 2004 | Neuroscience Resident Teacher of the Year, University of Florida | 2005 | Neurology Resident Teacher of the Year, University of Florida | 2006 | Neurology Resident Teacher of the Year, University of Florida | 2006 | Alpha Omega Alpha (Staff Member), University of Florida College of Medicine | 2009 | Clinical Excellence Award “Organ Donation”, University of Massachusetts | 2010 | Clinical Excellence Award “Acute Stroke Team Member”, University of Massachusetts | 2011 | Clinical Excellence Award “Organ Donation”, University of Massachusetts | 2011 - 2012 | Faculty Scholar Award (awarded to women faculty at UMASS Medical School for outstanding research), University of Massachusetts Medical School | 2012 - 2014 | Councilor, CCEN Section, AAN | 2013 | Presidential Citation for Outstanding Contributions to Neurocritical Care, Neurocritical Care Society | 2013 - 2017 | Board of Directors, 1st term, Neurocritical Care Society | 2014 - 2016 | Executive Committee Member, Critical Care and Emergency Neurology (CCEN) Section AAN | 2014 - 2015 | Executive Committee Member, Neurocritical Care Society | 2014 | Fellow of Neurocritical Care Society (FNCS), Neurocritical Care Society | 2016 | Fellow of Critical Care Medicine (FCCM), American College of Critical Care Medicine | 2017 - 2019 | Presidential Citation for Outstanding Contributions to Neurocritical Care, Neurocritical Care Society | 2018 - 2019 | "Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants), American Academy of Neurology | 2019 | Fellow of American Academy of Neurology (FAAN), American Academy of Neurology | 2019 - 2023 | Board of Directors (2nd term), Neurocritical Care Society | 2020 | Nominee, Chancellor's Award for Excellence in Mentoring, University of Massachusetts Medical School |
Overview Dr. Muehlschlegel is an Associate Professor of Neurology, Anesthesiology and Surgery and practices as a clinician and investigator in Neurocritical Care. She completed clinical training in neurology, vascular neurology and neurocritical care, and is triple board certified in these subspecialties. She has obtained additional research training through the completion of the Harvard School of Public Health Summer Program for Clinical Effectiveness and Masters of Public Health Program, with a focus in Clinical Effectiveness. She is a clinician-scientist, and her goal and vision is to improve the clinical care and the outcomes of critically ill patients (and their families) with neurological emergencies through evidence based medicine and cutting edge research. Dr. Muehlschlegel's clinical research laboratory engages in NIH and industry-funded research in collaboration with national and international teams to achieve this ultimate goal. Her research program focuses on outcome prognostication and shared decision making in patients with moderate-severe traumatic brain injury (TBI), large acute ischemic stroke and intracerebral hemorrhage. https://umassmed.edu/nccresearch Dr. Muehlschlegel's passion is to mentor trainees (UMMS medical students, residents, fellows, visiting research scholars) and junior faculty to promote curiosity and scientific rigor, and share her love for neurocritical care and academic medicine. She actively promotes women in STEM and Neurocritical Care. From 2018 - 2020 she served as the Co-Director, and since 2020 as the Director of the UMMS Junior Faculty Development Program (JFDP) sponsored by the Office of Faculty Affairs, a national model of junior faculty development. https://www.umassmed.edu/ofa/development/JFDP/ Clinical research opportunities are available for medical and PhD students, residents and junior faculty upon request. We are currently not hiring paid research staff. We cannot accept basic scientists. Please read up on our research first before applying. Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Mainali S, Moheet AM, McCredie VA, Livesay S, Manners J, Rhoney DH, Muehlschlegel S. The Neurocritical Care Society Gender Parity Analysis in Grants and Recognition Awards. Neurocrit Care. 2021 Jan 13. PMID: 33442813.
-
Moheet AM, Mainali S, McCredie VA, Livesay S, Manners J, Rhoney DH, Muehlschlegel S. A Longitudinal Study of Gender Parity Trends of General Membership and Leadership in the Neurocritical Care Society between 2002 and 2019. Neurocrit Care. 2020 Oct 27. PMID: 33108626.
-
Muehlschlegel S, Hwang DY, Flahive J, Quinn T, Lee C, Moskowitz J, Goostrey K, Jones K, Pach JJ, Knies AK, Shutter L, Goldberg R, Mazor KM. Goals-of-care decision aid for critically ill patients with TBI: Development and feasibility testing. Neurology. 2020 Jun 17. PMID: 32554766.
-
Ditch KL, Flahive JM, West AM, Osgood ML, Muehlschlegel S. Hyperchloremia, not Concomitant Hypernatremia, Independently Predicts Early Mortality in Critically Ill Moderate-Severe Traumatic Brain Injury Patients. Neurocrit Care. 2020 Feb 10. PMID: 32043263.
-
Muehlschlegel S. Ready or Not (To Apply)? Autoregulatory Dysfunction Indices and Lesion Progression in Traumatic Brain Injury. Neurocrit Care. 2019 Dec 16. PMID: 31845171.
-
Silver B, Hamid T, Khan M, DiNapoli M, Behrouz R, Saposnik G, Sarafin JA, Martin S, Moonis M, Henninger N, Goddeau R, Jun-O'Connell A, Cutting SM, Saad A, Yaghi S, Hall W, Muehlschlegel S, Carandang R, Osgood M, Thompson BB, Fehnel CR, Wendell LC, Potter NS, Gilchrist JM, Barton B. 12 versus 24 h bed rest after acute ischemic stroke thrombolysis: a preliminary experience. J Neurol Sci. 2019 Dec 05; 409:116618. PMID: 31837536.
-
Wartenberg KE, Hwang DY, Haeusler KG, Muehlschlegel S, Sakowitz OW, Madžar D, Hamer HM, Rabinstein AA, Greer DM, Hemphill JC, Meixensberger J, Varelas PN. Correction to: Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society. Neurocrit Care. 2019 Aug 21. PMID: 31435836.
-
Gibbons PW, Goldberg RJ, Muehlschlegel S. A pilot study evaluating a simple cardiac dysfunction score to predict complications and survival among critically-ill patients with traumatic brain injury. J Crit Care. 2019 Aug 08; 54:130-135. PMID: 31446230.
-
Wartenberg KE, Hwang DY, Häusler KG, Muehlschlegel S, Sakowitz OW, Madžar D, Hamer HM, Rabinstein AA, Greer DM, Hemphill JC, Meixensberger J, Varelas PN. Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society. Neurocrit Care. 2019 Jul 31. PMID: 31368059.
-
Hutchinson PJ, Kolias AG, Tajsic T, Adeleye A, Aklilu AT, Apriawan T, Bajamal AH, Barthélemy EJ, Devi BI, Bhat D, Bulters D, Chesnut R, Citerio G, Cooper DJ, Czosnyka M, Edem I, El-Ghandour NMF, Figaji A, Fountas KN, Gallagher C, Hawryluk GWJ, Iaccarino C, Joseph M, Khan T, Laeke T, Levchenko O, Liu B, Liu W, Maas A, Manley GT, Manson P, Mazzeo AT, Menon DK, Michael DB, Muehlschlegel S, Okonkwo DO, Park KB, Rosenfeld JV, Rosseau G, Rubiano AM, Shabani HK, Stocchetti N, Timmons SD, Timofeev I, Uff C, Ullman JS, Valadka A, Waran V, Wells A, Wilson MH, Servadei F. Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury : Consensus statement. Acta Neurochir (Wien). 2019 May 28. PMID: 31134383.
-
Damani R, Mayer S, Dhar R, Martin RH, Nyquist P, Olson DM, Mejia-Mantilla JH, Muehlschlegel S, Jauch EC, Mocco J, Mutoh T, Suarez JI. Common Data Element for Unruptured Intracranial Aneurysm and Subarachnoid Hemorrhage: Recommendations from Assessments and Clinical Examination Workgroup/Subcommittee. Neurocrit Care. 2019 May 14. PMID: 31090013.
-
Mikati AG, Flahive J, Khan MW, Vedantam A, Gopinath S, Nordness MF, Robertson C, Patel MB, Sheth KN, Muehlschlegel S. Multicenter Validation of the Survival After Acute Civilian Penetrating Brain Injuries (SPIN) Score. Neurosurgery. 2019 May 07. PMID: 31065707.
-
Miller MM, Lowe J, Khan M, Azeem MU, Muehlschlegel S, Jun-O'Connell AH, Goddeau RP, Moonis M, Gritters D, Silver B, Henninger N. Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage. Neurocrit Care. 2019 Jan 28. PMID: 30690686.
-
Ghasemi M, Azeem MU, Muehlschlegel S, Chu F, Henninger N. Prescription patterns for routine EEG ordering in patients with intracranial hemorrhage admitted to a neurointensive care unit. J Crit Care. 2019 Jan 11; 50:262-268. PMID: 30660914.
-
Muehlschlegel S. Subarachnoid Hemorrhage. Continuum (Minneap Minn). 2018 Dec; 24(6):1623-1657. PMID: 30516599.
-
Khan MW, Muehlschlegel S. Shared Decision Making in Neurocritical Care. Neurosurg Clin N Am. 2018 Apr; 29(2):315-321. PMID: 29502720.
-
Moskowitz J, Quinn T, Khan MW, Shutter L, Goldberg R, Col N, Mazor KM, Muehlschlegel S. Should We Use the IMPACT-Model for the Outcome Prognostication of TBI Patients? A Qualitative Study Assessing Physicians' Perceptions. MDM Policy Pract. 2018 Jan-Jun; 3(1):2381468318757987. PMID: 30288437.
-
Henninger N, Compton RA, Khan MW, Carandang R, Hall W, Muehlschlegel S. "Don't lose hope early": Hemorrhagic diffuse axonal injury on head computed tomography is not associated with poor outcome in moderate to severe traumatic brain injury patients. J Trauma Acute Care Surg. 2018 Mar; 84(3):473-482. PMID: 29140952.
-
Humble SS, Wilson LD, Wang L, Long DA, Smith MA, Siktberg JC, Mirhoseini MF, Bhatia A, Pruthi S, Day MA, Muehlschlegel S, Patel MB. Prognosis of Diffuse Axonal Injury with Traumatic Brain Injury. J Trauma Acute Care Surg. 2018 Feb 17. PMID: 29462087.
-
Khan MW, Muehlschlegel S. Shared Decision Making in Neurocritical Care. Neurol Clin. 2017 Nov; 35(4):825-834. PMID: 28962816.
-
Quinn T, Moskowitz J, Khan MW, Shutter L, Goldberg R, Col N, Mazor KM, Muehlschlegel S. What Families Need and Physicians Deliver: Contrasting Communication Preferences Between Surrogate Decision-Makers and Physicians During Outcome Prognostication in Critically Ill TBI Patients. Neurocrit Care. 2017 Oct; 27(2):154-162. PMID: 28685395.
-
Osgood M, Muehlschlegel S. POINT: Should Continuous Venovenous Hemofiltration Always Be the Preferred Mode of Renal Replacement Therapy for the Patient With Acute Brain Injury? Yes. Chest. 2017 12; 152(6):1109-1111. PMID: 28911910.
-
Osgood M, Muehlschlegel S. Rebuttal From Drs Osgood and Muehlschlegel. Chest. 2017 12; 152(6):1114-1115. PMID: 28911912.
-
Marehbian J, Muehlschlegel S, Edlow BL, Hinson HE, Hwang DY. Medical Management of the Severe Traumatic Brain Injury Patient. Neurocrit Care. 2017 Jun 01. PMID: 28573388.
-
Cheng K, Bassil R, Carandang R, Hall W, Muehlschlegel S. The Estimated Verbal GCS Subscore in Intubated Traumatic Brain Injury Patients-Is it Really Better? J Neurotrauma. 2016 Dec 02. PMID: 27774844.
-
Muehlschlegel S, Ayturk D, Ahlawat A, Izzy S, Scalea TM, Stein DM, Emhoff T, Sheth KN. Predicting survival after acute civilian penetrating brain injuries: The SPIN score. Neurology. 2016 Nov 22; 87(21):2244-2253. PMID: 27784772.
-
Ahlawat A, Carandang R, Heard SO, Muehlschlegel S. The Modified Apnea Test During Brain Death Determination: An Alternative in Patients With Hypoxia. J Intensive Care Med. 2016 Jan; 31(1):66-9. PMID: 26574562.
-
Cai X, Robinson J, Muehlschlegel S, White DB, Holloway RG, Sheth KN, Fraenkel L, Hwang DY. Patient Preferences and Surrogate Decision Making in Neuroscience Intensive Care Units. Neurocrit Care. 2015 Aug; 23(1):131-41. PMID: 25990137.
-
Muehlschlegel S, Shutter L, Col N, Goldberg R. Decision Aids and Shared Decision-Making in Neurocritical Care: An Unmet Need in Our NeuroICUs. Neurocrit Care. 2015 Aug; 23(1):127-30. PMID: 25561435.
-
Osgood M, Compton R, Carandang R, Hall W, Kershaw G, Muehlschlegel S. Rapid unexpected brain herniation in association with renal replacement therapy in acute brain injury: caution in the neurocritical care unit. Neurocrit Care. 2015 Apr; 22(2):176-83. PMID: 25228117.
-
Henninger N, Izzy S, Carandang R, Hall W, Muehlschlegel S. Severe leukoaraiosis portends a poor outcome after traumatic brain injury. Neurocrit Care. 2014 Dec; 21(3):483-95. PMID: 24752459.
-
Muehlschlegel S, Carandang R, Hall W, Kini N, Izzy S, Garland B, Ouillette C, van der Bom IM, Flood TF, Gounis MJ, Weaver JP, Barton B, Wakhloo AK. Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial. J Neurol Neurosurg Psychiatry. 2015 Sep; 86(9):1029-35. PMID: 25344064.
-
Izzy S, Muehlschlegel S. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage and traumatic brain injury. Curr Treat Options Neurol. 2014 Jan; 16(1):278. PMID: 24347030.
-
Izzy S, Compton R, Carandang R, Hall W, Muehlschlegel S. Self-fulfilling prophecies through withdrawal of care: do they exist in traumatic brain injury, too? Neurocrit Care. 2013 Dec; 19(3):347-63. PMID: 24132565.
-
Muehlschlegel S, Kursun O, Topcuoglu MA, Fok J, Singhal AB. Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage. JAMA Neurol. 2013 Oct; 70(10):1254-60. PMID: 23939614.
-
Muehlschlegel S, Carandang R, Ouillette C, Hall W, Anderson F, Goldberg R. Frequency and impact of intensive care unit complications on moderate-severe traumatic brain injury: early results of the Outcome Prognostication in Traumatic Brain Injury (OPTIMISM) Study. Neurocrit Care. 2013 Jun; 18(3):318-31. PMID: 23377884.
-
Tisdell J, Smith TW, Muehlschlegel S. Multiple septic brain emboli in infectious endocarditis. Arch Neurol. 2012 Sep; 69(9):1206-7. PMID: 22964915.
-
Rivera-Lara L, Zhang J, Muehlschlegel S. Therapeutic hypothermia for acute neurological injuries. Neurotherapeutics. 2012 Jan; 9(1):73-86. PMID: 22173727.
-
Muehlschlegel S, Rordorf G, Sims J. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke. 2011 May; 42(5):1301-6. PMID: 21454813.
-
Muehlschlegel S, Selb J, Patel M, Diamond SG, Franceschini MA, Sorensen AG, Boas DA, Schwamm LH. Feasibility of NIRS in the neurointensive care unit: a pilot study in stroke using physiological oscillations. Neurocrit Care. 2009; 11(2):288-95. PMID: 19649749.
-
Muehlschlegel S, Voetsch B, Sorond FA. Emergent epidural blood patch: lifesaving treatment of paradoxical herniation. Arch Neurol. 2009 May; 66(5):670-1. PMID: 19433672.
-
Muehlschlegel S, Sims JR. Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit Care. 2009; 10(1):103-15. PMID: 18696266.
-
Muehlschlegel S, Rordorf G, Bodock M, Sims JR. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series. Neurocrit Care. 2009; 10(1):116-21. PMID: 18696267.
-
Muehlschlegel S, Goddeau RP, Sims JR. Teaching NeuroImage: Cerebral T-waves from an aneurysmal cardunculus compression. Neurology. 2008 Feb 12; 70(7):e28-9. PMID: 18268239.
-
Muehlschlegel S, Voetsch B, Singhal AB. CT angiography and CT perfusion in post-CEA hyperperfusion syndrome. Neurology. 2007 Apr 24; 68(17):1437. PMID: 17452594.
-
Muehlschlegel S, Dunser MW, Gabrielli A, Wenzel V, Layon AJ. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care. 2007; 6(1):3-10. PMID: 17356185.
-
Muehlschlegel S, Lobato EB. Con: all cardiac surgical patients should not have intraoperative cerebral oxygenation monitoring. J Cardiothorac Vasc Anesth. 2006 Aug; 20(4):613-5. PMID: 16884999.
-
Muehlschlegel S, Okun MS, Foote KD, Coco D, Yachnis AT, Fernandez HH. Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Mov Disord. 2005 Nov; 20(11):1523-7. PMID: 16037914.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2005 | 1 | 2006 | 1 | 2007 | 2 | 2008 | 3 | 2009 | 2 | 2011 | 1 | 2012 | 2 | 2013 | 3 | 2014 | 3 | 2015 | 4 | 2016 | 2 | 2017 | 5 | 2018 | 5 | 2019 | 10 | 2020 | 3 | 2021 | 1 |
To return to the timeline, click here.
For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
|
Muehlschlegel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|